Verbatim response from Claude
Wegovy vs Zepbound: Quick Comparison
The Drugs
Wegovy (semaglutide)
- GLP-1 receptor agonist
- ~15% average weight loss in trials
- Made by Novo Nordisk
- Weekly injection
Zepbound (tirzepatide)
- Dual GLP-1/GIP receptor agonist
- ~20-22% average weight loss in trials
- Made by Eli Lilly
- Weekly injection
- Generally considered more effective based on current data
Which to Ask For?
Zepbound has the edge for most people purely on effectiveness numbers. However, your doctor may prefer Wegovy if you have specific cardiovascular risk factors, since semaglutide has more long-term cardiovascular data currently.
Where to Get Either Online
Reputable telehealth options:
- Hims & Hers – offers both, competitive pricing
- Ro (Roman) – strong medical support
- WeightWatchers Clinic – combines program with medication
- Noom Med – similar combo approach
- Found – good for ongoing support
⚠️ Important warnings:
- Avoid any site that doesn't require a real medical consultation
- Compounded semaglutide/tirzepatide has FDA safety concerns
- Insurance coverage varies significantly
Talk to a licensed provider to determine which fits your health history.